(secondQuint)Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients.

 Patients are randomized to receive blinded stavudine extended release (d4T ER) or immediate release (d4T IR) formulation.

 Randomization is balanced by screening HIV viral load of less than 30,000 copies/ml or at least 30,000 copies/ml and by site.

 Patients also receive open-label efavirenz (EFV) and lamivudine (3TC).

 Efficacy is evaluated over 48 weeks of the dosing period and safety is evaluated over the entire dosing period (56 weeks).

.

 Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients@highlight

The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T).

 One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).

